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ABSTRACT: Significant levels of infectious diseases caused by 
pathogenic bacteria are nowadays a worldwide concern implying 
considerable public healthcare challenges and huge economic det-
riment. Due to the fast spread of these bio-threat agents and the 
outbreak of diseases, a rapid detection of pathogens at early stages 
is crucial, particularly in low-resource settings. To this aim, we de-
veloped for the first time a new sensing approach carried out in a 
single-step for Escherichia coli O157:H7 detection. The detection 
principle is based on Förster Resonance Energy Transfer using gold 
nanoclusters as signal reporter and gold nanoparticles conjugated 
with antibodies as a quencher. The sensing platform includes and 
UV-LED to provide the proper excitation and consists in a micro-
tube containing two pieces of fiber glass; one of them is embedded 
with label-free gold nanoclusters and the other one with gold nano-
particles conjugated with antibodies. Upon the addition of the sam-
ple containing bacteria the florescence of gold nanoclusters is re-
covered. The assay was evaluated by naked eye (on/off) and quan-
titatively using a smartphone camera. The biosensor proved to be 
highly specific and sensitive, achieving a limit of detection as low 
as 4.0 CFU ml-1. Additionally, recoveries of 110% and 95% were 
obtained when evaluating the platform in spiked river and tap water 
respectively.   
Keywords: Point-of-Care; Biosensor; Optical detection; Bacteria 
detection; FRET; Smartphone-based detection  
Nowadays, Escherichia coli O157:H7 (E. coli O157:H7) is one of 
the major threats to public healthcare causing serious infectious dis-
eases mainly through contaminated water and food 1, 2. Since the 
causative pathogen agent can spread rapidly, it is imperative to 
achieve fast diagnosis. In addition, providing a quick decision in 
the field to test the safety of water and food will have a great effect 
on controlling and minimizing mortality rate and financial afflic-
tion. 
Traditional methods for the identification and detection of patho-
genic bacteria are mainly based on plate cultivation3, enzyme-
linked immunosorbent assay (ELISA) and polymerase chain reac-
tion (PCR)4-6. Culturing method requires long analysis time (∼ 
days) and special labor operation. PCR and ELISA need significant 
instruments, manpower, expense and time that already are not suit-
able for emergency cases especially in developing countries where 
medical facilities are unobtainable 7. 
To overcome the aforementioned problems, point-of-care (PoC) di-
agnostic can be a potential solution for improving the global health 
managements 8. Toward this important goal, different PoC devices 
for detection of E. coli have been implemented including colori-
metric-based lateral flow immunoassay (LFIA) 9-11 and other non-
paper-based microfluidic devices based on electrochemical detec-
tion 12, colorimetry13, 14, fluorimetry15  and magneto-fluorimetry16. 
LFIA are limited by their poor sensitivity that usually requires sig-
nal amplification, while the other microfluidic systems are rela-
tively expensive and require trained personnel17, 18. Therefore, there 
is a lack of a suitable PoC device to detect of E. coli for in field 
assays. 
Our research group have been involved in developing photolumi-
nescence paper-based platforms for detecting E. coli 19, 20. The re-
ported strategies are related to nanoswitch “Off-On” methodology 
using photoluminescent quantum dots conjugated with antibodies. 
In these platforms, despite of being sensitive and specific, there are 
some drawbacks such as multistep procedures, exclusive readers 
platforms and particularly the easy to use for end-user that reduce 
the applicability of these biosensors for in-field measurements. 
Previous studies have reported the quenching of gold nanoclusters 
(AuNCs) fluorescence in the presence of gold nanoparticles 
(AuNPs) 21. This phenomenon occurs due to the complementary 
overlapping between the surface plasmon resonance absorption 
wavelength of AuNp and the fluorescence emission wavelength of 
AuNCs. Some biosensors have been developed by exploiting this 
phenomenon such as the detection of cholesterol22 and uric acid 23. 
In these cases, the detection is carried out through the production 
of H2O2 in an enzymatic reaction, AuNPs seeds start growing, in-
creasing the absorbance of AuNPs with the consequently decrease 
in the fluorescence emission of AuNCs. Although this strategy has 
been exploited for biosensing applications, so far, to the best of our 
knowledge none of these nanomaterials have being used together 
as an immunosensor. Specifically, if we are starting from the OFF 
state, fluorescence could be recovered if the distance between the 
donor/acceptor pair becomes big enough 
Certainly E. coli bacteria is big enough to promote this effect. For 
this purpose, we developed a simple, fast and cost-effective “lab on 
a tube” platform for E. coli detection. The proposed approach relies 




on gold nanoclusters (AuNCs) as energy donor and antibody-func-
tionalized AuNPs as energy acceptor. This enables an ON/OFF flu-
orescent signal depending on the presence or absence of E. coli in 
the sample. The assay is carried out inside a microtube that contains 
the reagents embedded in glass fiber membrane. In this regard, the 
biosensor can be easily transported and stored up to use. The assay 
starts by just introducing the sample into the micro-tube. After 20 
minutes of incubation, the result can be evaluated by naked eye, in 
which the presence or absence of fluorescence indicates a yes/no 
response to the bacteria. Conveniently, it can be evaluated quanti-
tatively by using a 3D printed device with an UV-LED, a 
smartphone camera and an image-analysis app. 
 
EXPERIMENTAL SECTION 
Materials and Instruments. All commercial reagents are analyti-
cal grade and handled according to the material safety data sheets 
suggested by the suppliers. Hydrogen tetrachloroaurate (III) dehy-
drate (HAuCl4 3H2O, 99.9%), Trisodium Citrate, Sodium hydrox-
ide, Phosphate buffered saline tablet (P4417), bovine serum albu-
min (BSA), were purchased from Sigma-Aldrich (Madrid, Spain). 
Anti-E.coli antibody (Ab, ab68451) was obtained from Abcam 
(Cambridge, UK). Escherichia coli O157:H7 (CECT 4783, E. coli) 
and Salmonella Typhimurium (CECT 722T, S. typhimurium) 
strains were obtained from Sigma-Aldrich   (Madrid, Spain). Ana-
lytical grade nitric acid and hydrochloric acid were purchased from 
Fisher Scientific Fiber glass membrane (GFCP00080000) was pur-
chased from Millipore. All glassware were washed with aqua regia, 
and rinsed three times with Milli-Q water. Transmission electron 
microscopy (TEM) images were performed with a FEI Tecnai G2 
20 TWIN electron microscope. Fluorescence emission and Absorb-
ance spectra were collected on a Microplate reader (Molecular de-
vice). TS-100 Thermo-Shaker (Biosan, Riga, Latvia) was used as 
the stirrer for functionalization of AuNPs with antibodies. 
Synthesis of BSA-AuNCs. BSA-AuNCs were synthesized accord-
ing to a previous protocol24. Briefly, aqueous solutions of HAuCl4 
(10 mM, 5 ml) and BSA (50 mg/ml, 5 ml) were mixed and sub-
jected to vigorous stirring at 37°C. After 2 min, NaOH solution (1.0 
M, 0.5 mL) was added into the reaction mixture. The reaction con-
tainer was sealed and allowed to proceed in the dark for 12 h. The 
solution became deep brown and showed strong red emission under 
a 365-nm UV lamp, pointing out the formation of the AuNCs. The 
prepared AuNCs were purified through dialysis membrane 
(MWCO: 1 kDa) against Milli-Q water for one day to remove un-
reacted HAuCl4 and sodium hydroxide. Purified AuNCs were kept 
at 4°C for further use. The concentration of BSA-AuNCs was esti-
mated at around 20 mg/ml. 
Synthesis and conjugation of AuNPs. The synthesis of AuNPs 
was performed following the protocol reported by Bastús and co-
workers 25. In short, the initial AuNPs seeds were prepared by boil-
ing 150 mL of sodium citrate (2.2 mM) in a sealed condenser, fol-
lowed by the injection of 1 ml of HAuCl4 (25 mM). After 10 
minutes, the color of the solution turned from light yellow to pink 
and it was cooled up to 90 °C. Next, 1 ml of sodium citrate (60mM) 
was added and after 2 min, 1 ml of HAuCl4 (25mM) was sequen-
tially added. The solution was kept under stirring at 90 °C for 30 
min and the color of solution finally became wine-red. The final 
concentration of the AuNPs solution was 3.1 × 1011 NPs/ml.  
The AuNPs were bioconjugated with antibodies against E. coli fol-
lowing the procedure previously reported by our group26 . First the 
pH of the AuNPs was adjusted to 8.9 using Borate buffer (10 mM). 
Next, 100 μL of anti-E. coli (200 μg/mL) were incubated with 1.5 
ml AuNPs for 24 h at 350 rpm and 4 °C. Then 100 μL BSA solution 
in Milli-Q water (final concentration 1%(w/w)) was added to the 
conjugated AuNPs followed by an incubation for 1 h under the pre-
vious conditions. The excess of antibodies and BSA were removed 
by centrifuging the solution at 14 000 rpm and 4 °C for 30 min, 
followed by re-suspension with 200 µL of Milli-Q water. Finally 
the conjugated AuNPs where stored in 4°C for further use. 
Platform fabrication. The glass fiber membranes were cut into a 
15 cm × 8 mm strips.  800 μL of the conjugated AuNPs and AuNCs 
where drop-casted on separate glass fiber strips and dried in a vac-
uum chamber for 2.5 hours. Finally they were cut in circles (diam-
eter ≈ 0.6 cm) using a hole puncher and introduced in the micro-
tubes. 
Bacteria preparation. Stock solution (1010 E. coli/ml) of bacteria 
was prepared by dissolving 10 mg E. coli in 1 ml filtered Milli Q 
water followed by shaking with vortex. In order to determine the 
concentration of the prepared stock solution, the optical density at 
600 nm (OD600) was measured using a spectrophotometer and cor-
roborated with Agilent geometry software 
(https://www.chem.agilent.com/store/biocalculators/calcODBacte
rial.jsp). Standard serial solutions of E. coli (0 - 108 CFU/ml) were 
prepared by diluting the suspension stock solution (1010 CFU/ml 
≈ 1010 E. coli/ml) in PBS. 
 
Assay performance. Serial dilutions of E. coli (0 - 108 CFU/ml) 
where prepared in PBS, 200 μL where drop-casted in the microtube 
and incubated for 20 min in room temperature. The assay was eval-
uated with a spectrophotometer by transferring the solution into a 
microplate. The fluorescence intensity was measured at 665 nm 
(Ext. 365 nm) for each dilution of E. coli and normalized with the 
black (F-F0), where F and F0 corresponded to sample with and with-
out E. coli, respectively. For a point-of-care application, the assay 
was evaluated by taking a picture using a mobile phone camera and 
analyzing it with ImageJ software (National Institutes of Health, 
Maryland, USA) following the protocol already reported by our 
group27. All the experiments were replicated three times. 
 
RESULTS AND DISCUSSION 
Assay principle. The assay was performed in a polypropylene mi-
crotube, which was used as a reservoir and detection platform. 
Firstly, the fluorescent AuNCs were synthesized, purified and 
drop-casted on a fiberglass membrane. The fiber glass was then 
dried using a vacuum desiccator and cut into circular pieces (Ø 0.6 
cm) using a hole puncher. The pieces were introduced into the mi-
crotube and stored until running the assay. The same procedure was 
done for the AuNPs, which were previously conjugated with anti-
bodies against E. coli O157:H7 following the procedure reported in 
the experimental section (Figure 1A). In this way, the micro-tube 
stocked both conjugate pads, one containing the sensing PL probe 
(AuNCs) and the other containing the quencher label (AuNPs). The 
fiber glass was used as a porous material with high absorption and 
release capacity of solutions, appropriate long-term storage of sam-
ples, high stability and good flexibility 28, 29. In order to evaluate 
the presence of E. coli in a real environment, the assay starts by 
introducing the sample solution into the microtube followed by a 
20 minutes incubation step (Figure 1B). The sample solution ena-
bles the rehydration of the conjugate pad and the eventual release 
of the stored nanomaterials to the solution. The biosensing mecha-
nism is based on Förster Resonance Energy Transfer (FRET), being 
the AuNPs and AuNCs the energy acceptors and donors, respec-
tively. In this regard, the AuNPs were able to quench the fluores-
cence emission of the AuNCs when they were close together. This 
is known as the “turn-off” mode, which is linked to the absence of 




antibody-functionalized AuNPs is attached to the surface of the 
bacteria avoiding the approach of the AuNCs. In this way, due to 
the fact that FRET mechanism is possible up to 30 nm and E. coli 
where 1µm sized 30, the fluorescence signal was restored, switching 
to a “turn-on” mode (Figure 1C). It should be noticed the specific-
ity of the assay. In this regard, AuNCs were mixed with AuNPs 
with and without bacteria. It can be observed in Figure S1 that 
there is no recovery in the fluorescence of AuNCs when AuNPs are 
not conjugated with antibodies. 
Finally, a quantitative outcome was obtained using a smartphone 
camera. Nowadays, almost any smartphone has a good quality 
CMOS sensor and the possibility to fix the picture parameters such 
as shutter speed, ISO and focus, obtaining reproducible and accu-
rate images. In this regard, a 3D printed device was developed to 
introduce the micro-tube using the cap as the sample holder. The 
device contains a 365 nm UV-LED to excite the AuNCs and a mi-
cro lens to adjust the focal length of the camera to the minimum 
possible (Figure 1D). The pictures were analyzed using ImageJ 
app (smartphone version) to transform the brightness levels into a 
numerical value, which allows quantification. Since most of the 
people across the world has a smartphone as a common equipment 
in our day-to-day life, this proof of concept makes a highly prom-
ising device for point-of-care assay and field applications without 




Figure 1. Schematic representation of the biosensing platform. (A) Two fiber glass strips embedded with AuNCs and AuNPs conjugated 
with anti-E. coli antibody respectively. (B) Operation principle; Sample is added directly to the micro-tube containing the two strips. (C) 
Naked eye evaluation of the ON/OFF switch mechanism. (D) Smartphone based device for quantitative evaluation of the E. coli concentra-
tion. 
 
Characterization of AuNCs and conjugated-AuNPs. The syn-
thesized AuNCs were characterized by transmission electron mi-
croscopy (TEM). As observed in Figure 2A, they have a uniform 
morphology and a narrow size distribution with an average diame-
ter of about 1.0 nm. Furthermore, a fluorescence emission peak at 
665 nm when excited at 365 nm and a strong red emission under 
UV light (Figure 2B). The synthesized AuNPs were also charac-
terized with TEM, as shown in Figure 2C and Figure 2D. AuNPs 
has a spherical and uniform size of around 40 nm. Besides, its con-
jugation to antibodies against E. coli was corroborated by the pres-
ence of red shift from 525 to 535 nm in the UV-vis spectrum, indi-
cating a modification on the AuNPs surface (Figure S2) 31. Finally, 
in order to achieve FRET, the absorbance spectrum of energy ac-
ceptor must be overlapped with the emission spectrum of the donor 
probe. This phenomenon can be observed in Figure 2B, where the 
emission spectrum of the AuNCs was clearly overlapped with the 







Figure 2. (A) TEM image of BSA-AuNCs. Inset: the size distribtion histogram of the as prepared AuNCs. (B) Fluorescence spectra of BSA-
AuNCs (red line) and absorption spectrum of conjugated AuNPs with Anti-E. coli (black line). Inset: Digital photo of AuNCs under UV 
light. (C) TEM image of Citrate stabilized- AuNPs. Inset: graph corresponds to size distribution diagram. (D) High magnified of as-prepared 
AuNPs. 
 
Assay optimization. The highest concentration with the higher flu-
orescence emission of AuNCs was tested to evaluate the size de-
pendence on the quenching efficiency of AuNPs. It is known that, 
the bigger the size of nanoparticles, the highest the red shift in the 
wavelength, causing more overlap with the emission of AuNCs 21. 
Among the tested sizes, 40 nm was selected as the most suitable for 
the assay (Figure S3). Besides bigger nanoparticles (>40nm) pro-
duce more quenching, the antibodies conjugation protocols are 
fully optimized for 40 nm. Moreover, if bigger nanoparticles are 
used the required amount of antibodies to cover the surface will be 
higher, causing a more expensive device. To evaluate how the 
AuNP concentration affects the quenching of AuNCs, the stock so-
lution (3.1 × 1011 NPs/ml) of AuNP was concentrated (by centrifu-
gation) and diluted. It can be observed in Figure 3A that indeed 
higher concentrations of AuNP produces more quenching on the 
light emission of AuNCs. Nevertheless, we have selected 1.16x1012 
NP/ml as a compromise between efficiency and affordability since 
there is no noteworthy quenching at higher concentrations. 
Furthermore, the antibody concentration on the AuNPs was also 
optimized as it dramatically affects the sensitivity and the cost-ef-
fectiveness of the platform (using less antibody can considerably 
reduce the development cost of the biosensor). This was done by 
performing the well-stablished gold aggregation test (GAT) 32, 
which determines the maximum concentration of antibody required 
to cover the AuNPs surface. Based on the results shown in Figure 
3B, we concluded that 175 μg/ml of anti-E. coli were enough to 
cover the surface of the AuNPs, however we round it up to 200 
μg/ml in the subsequent assays. 
The required concentration of AuNCs to achieve an effective FRET 
and recovery was another parameter to be optimized. In this con-
text, (AuNP at fixed concentration of 1.16x1012 NP/ml) the fluores-
cence recovery in presence of E. coli was evaluated using different 
AuNCs concentrations (from 0.5 to 8.0 mg/ml). As expected, an 
excess of AuNCs brought to signal saturation while a low concen-
tration of AuNCs let to negligible fluorescence intensity (Figure 
3C). Therefore, the fluorescence enhancement efficiency (F-F0) 
was employed as a criterion to evaluate the best signal where F and 
F0 correspond to the intensities of fluorescence of AuNCs/AuNPs 
system in the presence and absence of E. coli, respectively. Hereby, 







Figure 3. Optimization of experimental conditions. (A) Pre-optimization of the quenching efficiency due to AuNPs concentration (B) The 
effect of the concentration of the immobilized antibody on the surface of AuNPs (GAT) at NaCl 1 % and 0.58× 1012/ml AuNPs in various 
concentration of antibody (C) Effect of the concentration of AuNCs as a fluorophore agent on fluorescence recovery efficiency (F-F0) where 
F and F0 correspond to the fluorescence intensities of AuNCs/AuNPs system in the presence and absence of E. coli, respectively at 105 
CFU/mL E. coli (D) The effect of the concentration of anti-E. coli- labeled AuNPs on quenching efficiency (F0-F)/F0 where F and F0 corre-
spond to the fluorescence intensities of AuNCs in the presence and absence of Ab-AuNPs, respectively. The concentration of AuNCs was 
6.0 mg/ml. 
 
Although AuNPs concentration was previously optimized (pre op-
timization strategy) those nanoparticles were not conjugated with 
anti-E. coli antibodies. It is important to double check the concen-
tration of conjugated AuNPs required to achieve an effective FRET 
taking in consideration the previously optimized AuNCs concen-
tration. In this regard, conjugated AuNPs ranging from 0.31 to 4.46 
(x1012 NPs/mL) were evaluated. As observed in Figure 3D, 2.32 
(x1012 AuNPs/mL) allowed a 68% quenching efficiency, while 
higher and lower concentrations ended up with signal saturation 
and low quenching, respectively. It is also essential to optimize this 
parameter for fluorescence restoration efficiency (Figure S4). 
Therefore, this was the concentration of conjugated AuNPs se-
lected for the next experiments.  
Finally, in order to better understand the response rate of our plat-
form to E. coli detection, a comprehensive kinetic study was per-
formed (Figure S5) showing that the fluorescence signal increased 
exponentially and reached equilibrium after 20 minutes. This re-
veals the assay time required before performing the final evalua-
tion. 
Smartphone-based detection of E. coli. The developed platform 
was firstly evaluated under optimal conditions by spiking known 
concentrations of E. coli (0 to 107 CFU/mL) in PBS buffer (10 mM 
pH 7.4) and using a spectrophotometer. As observed in Figure 4A, 
the fluorescence signal gradually increases with higher concentra-
tion of E. coli, with a good correlation (exponential behavior log[E. 
coli]) in the range of 0 to 105 CFU/mL (Figure 4B), being F and F0 
the fluorescence intensities at 665 nm in the presence and absence 
of E. coli, respectively.  The limit of detection (LOD) was calcu-
lated as low as 1.37 CFU/mL based on 3 times “s/m” ratio, where 
“s” is the standard deviation of the blank fluorescence signal (three 
replicates) and “m” is the slope of the related calibration curve. Fur-
thermore, the assay was evaluated with a smartphone camera, in 




context, a Samsung galaxy S7 smartphone was used to take a pic-
ture of the microtubes after running the assay (20 minutes incuba-
tion). The micro-tube cap was irradiated under a UV LED (Ex. 365 
nm) and the smartphone was attached to a holder, the pictures were 
always taken in the same conditions; at ISO 100 and shooter speed 
1/60 s. As illustrated in Figure 4C, the sample containing 0 
CFU/mL of E. coli, defined as blank sample, is characterized by 
low brightness levels due to the “turn-off” FRET effect. However, 
with the increase of E. coli concentration there was a gradual in-
crease in fluorescence (“turn-on” mode). In order to obtain a nu-
merical value, the pictures were analyzed with Image J software, in 
which the fluorescence intensity is transformed into a value from 0 
to 255 (where 0 is dark and 255 is maximum brightness). The flu-
orescence intensity values were normalized with the signal corre-
sponding to absence of E. coli (F0). The calibration curve is ob-
served in Figure 4D, which shows a power fluorescence increase . 
It is worth to notice a change in the mathematical function in light 
of the results obtained with the fluorimeter and the smartphone. 
Graphing the values according to the function obtained with the 
fluorometer (log[E. coli]), it can be seen an exponential behavior 
which means that the results obtained with the smartphone follows 
a power function from 0 to 107 CFU/mL with a LOD of 4.0 
CFU/mL. (Figure 4D inset) 
The developed biosensor performance of E. coli detection was 
compared to some of the reported point of care sensors and sum-





Figure 4. Quantification of E. coli O157:H7 by developed biosensor. (A) Fluorescence spectrum of AuNCs/Ab-AuNPs upon addition of 
different concentrations of E. coli from 0 to 107 CFU/ mL. (B) Calibration curve of the assay by using fluorimeter. (F and F0 correspond to 
the fluorescence intensities of AuNCs/AuNPs system in the presence and absence of E. coli, respectively). (C) Typical images of AuNCs/Ab-
AuNPs system in the presence of various concentration of E. coli in the range of 0 - 107 CFU/mL (0, 103, 104, 105, 106 CFU/mL from left to 
right) captured by smartphone camera under 365 nm UV light irradiation; (D) Calibration curve resulted by processing images in the mobile 





Real samples evaluation. To further test the practicability of the 
biosensor, the assay was conducted by spiking known concentra-
tions of E. coli (102 and 105 CFU) to tap water and river water sam-
ples collected from river Ter (Vic, Spain). The samples were eval-
uated following the procedure previously reported and the recover-
ies where calculated by comparing the results obtained in real sam-
ples (i) with the ones obtained in PBS (ii), using the following equa-
tion:  
𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑦 (%) = 100 𝑥  (𝐹 − 𝐹0)𝑖/(𝐹 − 𝐹0)𝑖𝑖 
The results are summarized in Table 1. The obtained recoveries 
prove that there is no drastic interference when evaluating samples 
with a complex matrix, thus the developed platform can be applied 
for the detection of E. coli in real samples at the point-of-care.   
 
































a Recovery (%) =100 × (F-F0*/ F-F0#) 
 
Determination of the assays specificity. The specificity of the bi-
osensor toward E. coli was assessed by evaluation samples contain-
ing E.coli and Salmonella typhimurium, which is a similar family 
pathogen. Dilutions of E. coli, Salmonella and a mixture of both 
bacteria where spiked in PBS. The assay was carried out following 
the previous procedure. As shown in Figure 5, the normalized flu-
orescence (FL) intensity increased with higher concentrations of E. 
coli (0 to 105 CFU/mL). Conversely, the normalized FL intensity 
obtained for a sample with 105 CFU/mL of Salmonella was similar 
to the one obtained for 0 CFU of E. coli. This result prove that the 
developed biosensor was only specific for E. coli due to the AuNPs 
functionalization with highly specific antibodies against E. coli 
O157:H7. This was further corroborated by evaluating solutions 
containing a mixture of 105 CFU/mL Salmonella + 102 CFU/mL E. 
coli and 105 CFU/mL E. coli + 102 CFU/mL Salmonella. In the first 
case, the obtained signal was similar to the blank (0 CFU/mL E. 
coli) and in the second case the signal was similar to the one ob-
tained for 105 CFU/mL E. coli. Therefore, the results confirmed 
that the platform has a high specificity response and when applied 
in real samples, the achieved signal could be linked only to E. coli 
detection.  
Figure 5. Specificity of the developed fluorescence biosensor to-
ward E. coli in the presence of Salmonella as interfering bacteria. 
The error bars are the standard deviation of the three measurements. 
 
CONCLUSIONS 
The proposed all-in-one device combines outstanding advantage of 
both the glass fiber membrane as a cost-effective substrate with 
high loading capacity and the microtube platform as simple and 
portable set-up. Moreover, the detection method applied in the de-
veloped biosensor is fast (20 minutes) and doesn’t require washing 
steps.  It has proved to be highly sensitive and specific for detection 
of E. coli, although its application can be extended to other big an-
alytes. Finally, the possibility to do smartphone-based detection 
empowers the developed biosensor as unique PoC tests with real 
applicability in resource limited settings. 
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